company background image
3692 logo

Hansoh Pharmaceutical Group Informe acción SEHK:3692

Último precio

HK$17.40

Capitalización de mercado

HK$103.1b

7D

3.6%

1Y

22.7%

Actualizada

01 May, 2024

Datos

Finanzas de la empresa +

Hansoh Pharmaceutical Group Company Limited

Informe acción SEHK:3692

Capitalización de mercado: HK$103.1b

Resumen de acción 3692

Hansoh Pharmaceutical Group Company Limited, un holding de inversiones, se dedica a la investigación, desarrollo, fabricación y venta de productos farmacéuticos en la República Popular China.

3692 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends0/6

Recompensas

Análisis de riesgos

No se han detectado riesgos en 3692 a partir de nuestros controles de riesgos.

Competidores de Hansoh Pharmaceutical Group Company Limited

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Hansoh Pharmaceutical Group
Historical stock prices
Current Share PriceHK$17.40
52 Week HighHK$17.88
52 Week LowHK$9.41
Beta0.56
1 Month Change12.40%
3 Month Change46.71%
1 Year Change22.71%
3 Year Change-45.88%
5 Year Changen/a
Change since IPO-10.77%

Noticias y actualizaciones recientes

Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 01
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Recent updates

Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

May 01
Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

Mar 28
Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?

There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

Mar 04
There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Feb 16
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued

Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Dec 08
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly

Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Oct 12
Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate

Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

Sep 14
Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Sep 09
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 10
Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Jun 11
These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well

Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jan 23
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Dec 01
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Oct 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

Aug 28
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Jun 09
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

May 19
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing

Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

Apr 22
Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?

An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Feb 06
An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued

Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price

Nov 07
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price

Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

Oct 11
Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet

A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Jul 14
A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

The Hansoh Pharmaceutical Group (HKG:3692) Share Price Is Up 51% And Shareholders Are Holding On

Jan 31
The Hansoh Pharmaceutical Group (HKG:3692) Share Price Is Up 51% And Shareholders Are Holding On

Will Weakness in Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Stock Prove Temporary Given Strong Fundamentals?

Dec 08
Will Weakness in Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Stock Prove Temporary Given Strong Fundamentals?

Rentabilidad de los accionistas

3692HK PharmaceuticalsMercado HK
7D3.6%2.9%2.6%
1Y22.7%-15.1%-7.4%

Rentabilidad vs. Industria: 3692 superó al sector Hong Kong Pharmaceuticals , que obtuvo un rendimiento del -15.9% el año pasado.

Rentabilidad vs. Mercado: 3692 superó al mercado Hong Kong, que obtuvo un rendimiento del -10.1% el año pasado.

Volatilidad de los precios

Is 3692's price volatile compared to industry and market?
3692 volatility
3692 Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement7.4%
10% most volatile stocks in HK Market15.0%
10% least volatile stocks in HK Market3.6%

Precio estable de las acciones: El precio de las acciones de 3692 ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 3692 (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
19959,432Huijuan Zhongwww.hspharm.com

Hansoh Pharmaceutical Group Company Limited, un holding de inversiones, se dedica a la investigación, el desarrollo, la fabricación y la venta de productos farmacéuticos en la República Popular China. La empresa suministra productos para áreas terapéuticas como antitumorales, antiinfecciosas, enfermedades del sistema nervioso central, oncología, enfermedades metabólicas y autoinmunes, etc. Sus principales productos son Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Hengmu, Mailingda, Hengsen, XINYUE, Saint Luolai, Fulaimei, Pulaitan, Tanneng, Ameining, Oulanning, Ruibote, Fulaidi, Fulairui y comprimidos Puruian. La empresa atiende a distribuidores de productos farmacéuticos.

Resumen de fundamentos de Hansoh Pharmaceutical Group Company Limited

¿Cómo se comparan los beneficios e ingresos de Hansoh Pharmaceutical Group con su capitalización de mercado?
Estadísticas fundamentales de 3692
Capitalización bursátilHK$103.06b
Beneficios(TTM)HK$3.54b
Ingresos (TTM)HK$10.91b

29.1x

Ratio precio-beneficio (PE)

9.4x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 3692
IngresosCN¥10.10b
Coste de los ingresosCN¥1.03b
Beneficio brutoCN¥9.07b
Otros gastosCN¥5.79b
BeneficiosCN¥3.28b

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.55
Margen bruto89.78%
Margen de beneficio neto32.44%
Ratio deuda/patrimonio16.4%

¿Cómo se ha desempeñado 3692 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.6%

Rentabilidad actual por dividendo

35%

Ratio de pagos
¿Cuándo hay que comprar 3692 para recibir un próximo dividendo?
fechas de dividendos de Hansoh Pharmaceutical Group
Fecha ex dividendoJun 19 2024
Fecha de pago de dividendosJul 17 2024
Días hasta ex dividendo48 days
Días hasta la fecha de pago de dividendos76 days